A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
A recent study suggests that the US should standardize breast density reporting and require that all women receive notification.
The FDA’s Center for Devices and Radiological Health says that the agency and industry have reached agreement on MDUFA V.
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.
The FDA designated 213 submissions as breakthrough devices in 2021, the most awarded in a single year, by far.